We live in an era where the major global challenges—health-related, social, and environmental—urge us to reflect on the role of businesses in society. PMR has chosen to face this responsibility with a concrete, thoughtful, and meaningful gesture: supporting cancer research through a donation to the AIRC Foundation for Cancer Research.
This decision stems from a deep belief in the value of scientific innovation—not as an abstract goal, but as a tangible tool to improve people’s quality of life and contribute to a fairer, stronger, and more resilient society.
Research as a Common Good
Supporting science is not a symbolic act. It is a true investment in the future—an active commitment to progress and the protection of public health. Cancer research, in particular, represents one of the most advanced—and sensitive—frontiers of modern medicine. It is here that crucial battles for the dignity and survival of millions of people are being fought.
Our donation to AIRC is not a one-off initiative, but the expression of a deeply held conviction: every company has the power to act as a multiplier of public good. And in this sense, research is one of the highest and most transparent forms of common good. Supporting science does not only help the patients of today—it builds hope for those of tomorrow.
Corporate Responsibility Beyond Profit
At PMR, we have always understood our role not just in terms of economic performance, but as active participants in the communities where we operate. For us, corporate social responsibility is not a side note—it is a fundamental part of who we are. A company that operates ethically, that listens to the times we live in, and that chooses to serve its community through meaningful actions.
We chose to support cancer research because we believe that science needs allies. And that the business world must play a role in building a more evolved society—one capable of offering complex answers to complex problems.
An Ecosystem of Care
Science is not an isolated island. It is a system built on relationships, collaboration, and mutual trust. That is why, when a company chooses to support research, it enters an ecosystem that brings together institutions, researchers, healthcare providers, patients, and citizens. An ecosystem that works—silently, tirelessly—to push forward the boundaries of what is possible.
As Professor Francesco Perrone, President of the Italian Association of Medical Oncology, stated:
“Today, research is the true engine of clinical change. Every euro invested in clinical trials is an accelerator of solutions.”
This awareness lies at the heart of our commitment. Every scientific advancement generates ripple effects far beyond the laboratory—it touches hope, trust, and the right to care.
A Matter of Values, Not Opportunity
It is important for us to state this clearly: our decision to support AIRC does not stem from a communication strategy, but from a profound alignment with our core values. We are not seeking visibility—we are seeking meaning. And we believe that contributing to scientific progress is one of the noblest ways a company can express its identity.
The value of a decision lies in its authenticity. And we have chosen, with conviction, to walk the path of care, of knowledge, of life.
At PMR, we have chosen to stand with science, with medicine, and with the future. Because supporting research is a way to give back. But it is also a way to build forward.
Because every business, if it chooses to, can become a force for transformation. And we have chosen to be one.
